TIRZ-2
$89.99$109.99
Metabolic research
RETA-3 10MG
Triple incretin receptor agonist
A synthetic peptide investigated as a single-molecule agonist at the GIP, GLP-1, and glucagon receptors.
≥98% Purity U.S. Tested COA Included
| Classification | Synthetic polypeptide |
| Receptor targets | GIP · GLP-1 · Glucagon |
| CAS No. | 2381089-83-2 |
| Molar mass | ≈ 4,731 g/mol |
| Research focus | Metabolic & incretin signaling |
About this compound
RETA-3 (research designation for retatrutide, LY3437943) is a synthetic, multi-functional polypeptide studied as an agonist at three incretin-family receptors simultaneously: glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and the glucagon receptor. In the published literature it is a reference compound for studying energy homeostasis, incretin receptor pharmacology, and metabolic signaling pathways. PrimeLine Labs supplies RETA-3 strictly as an analytical reference material for in-vitro and laboratory research.
Specifications
- ≥ 99% purity (HPLC)
- Lyophilized white powder
- Store at -20 °C, protect from light
- Reconstitute with bacteriostatic water
Certificate of Analysis
The lot-specific Certificate of Analysis for this compound will be published in our COA library once third-party testing is complete.
Researcher Reviews
No reviews yet — be the first to review RETA-3.
Write a review
Sign in to write a review — reviews come from verified researchers.